Clare Market Investments LLC Dexcom Inc Transaction History

Clare Market Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Feb 20, 2025	SELL	$114.22 - $140.1 $273,899 - $335,959	-2,398 Closed	0 $0
Q4 2023 Feb 20, 2025	SELL	$75.49 - $124.16 $149,243 - $245,464	-1,977 Reduced 45.19%	2,398 $298 Million
Q3 2023 Feb 20, 2025	SELL	$86.06 - $137.93 $834,351 - $1.34 Million	-9,695 Reduced 68.91%	4,375 $408 Million
Q2 2023 Feb 20, 2025	BUY	$112.47 - $130.98 $1.58 Million - $1.84 Million	14,070 New	14,070 $1.81 Billion
Q1 2023 Feb 20, 2025	BUY	$104.0 - $122.92 $64,272 - $75,964	618 Added 11.03%	6,221 $723 Million
Q4 2022 Feb 20, 2025	BUY	$84.98 - $122.67 $189,080 - $272,940	2,225 Added 65.87%	5,603 $634 Million
Q3 2022 Feb 20, 2025	BUY	$76.35 - $94.18 $52,834 - $65,172	692 Added 25.76%	3,378 $272 Million
Q2 2022 Feb 20, 2025	BUY	$67.99 - $132.89 $113,203 - $221,261	1,665 Added 163.08%	2,686 $200 Million
Q1 2022 Feb 20, 2025	BUY	$94.08 - $130.2 $96,055 - $132,934	1,021 New	1,021 $522 Million

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Clare Market Investments LLC with notifications on news.